DENNIS M FENTON
CIK 1184627 · Executive V.P., Operations · last filed 2026-05-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$47.94M
Companies
10
Total Filings
57
Lifetime Open-Market Net
-$937.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TRAX | Director | 4,965 | — | — | $0 | 2 | 2026-05-14 |
| ANAB | Director | 4,965 | $56.07 | $278.4K | -$117.5K | 13 | 2026-01-08 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Director | 0 | — | — | $0 | 7 | 2020-07-02 |
| Sienna Biopharmaceuticals, Inc. (SNNA) Delisted | Director | 1,250 | — | — | $28.7K | 3 | 2019-06-03 |
| Pfenex Inc. (PFNX) Delisted | Director | — | — | — | $0 | 3 | 2017-05-08 |
| XENOPORT INC (XNPT) Delisted | Director | 0 | — | — | $10.3K | 9 | 2016-07-06 |
| KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted | Director | 1,476 | — | — | $0 | 5 | 2015-10-02 |
| HOSPIRA INC (HSP) Delisted | Director | 0 | — | — | $0 | 5 | 2015-09-03 |
| GENZYME CORP (GENZ) Delisted | Director | 2,375 | — | — | $0 | 2 | 2011-04-06 |
| AMGN | Executive V.P., Operations | 134,186 | $355.20 | $47.66M | -$858.9K | 5 | 2007-06-05 |
Recent Filings · Page 3 of 6
57 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-03-06 | ANAB | Grant (A) | — | $0 | EDGAR |
| 2017-09-19 | Sienna Biopharmaceuticals, Inc. (SNNA) Delisted | Buy (P) | +1,250 | $28.7K | EDGAR |
| 2017-06-19 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Grant (A) | +3,000 | $0 | EDGAR |
| 2017-05-08 | Pfenex Inc. (PFNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-07-06 | XENOPORT INC (XNPT) Delisted | Mixed | −24,300 | -$170.8K | EDGAR |
| 2016-06-20 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Grant (A) | +3,000 | $0 | EDGAR |
| 2016-05-19 | XENOPORT INC (XNPT) Delisted | Mixed | +5,000 | $0 | EDGAR |
| 2016-05-09 | Pfenex Inc. (PFNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-10-02 | KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted | Disp (D) | −3,348 | $0 | EDGAR |
| 2015-09-15 | Pfenex Inc. (PFNX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.